October 23, 2024 05:41 PM EDT
Pharma
FDA+

Adults 50 and up should get pneu­mo­coc­cal vac­cine, CDC ad­vi­sors say, in boost to Pfiz­er and Mer­ck

Max Bayer

Pharma Reporter

More peo­ple are now ad­vised to get a pneu­mo­coc­cal vac­cine if they haven’t al­ready, as CDC ad­vi­sors rec­om­mend­ed the shots for adults 50 and old­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times